Skip to main content
Erschienen in:

20.12.2017

Palliative Oncologic Care Curricula for Providers in Resource-Limited and Underserved Communities: a Systematic Review

verfasst von: Melody J. Xu, David Su, Rebecca Deboer, Michael Garcia, Peggy Tahir, Wendy Anderson, Anne Kinderman, Steve Braunstein, Tracy Sherertz

Erschienen in: Journal of Cancer Education | Ausgabe 2/2019

Einloggen, um Zugang zu erhalten

Abstract

Familiarity with principles of palliative care, supportive care, and palliative oncological treatment is essential for providers caring for cancer patients, though this may be challenging in global communities where resources are limited. Herein, we describe the scope of literature on palliative oncological care curricula for providers in resource-limited settings. A systematic literature review was conducted using PubMed, Embase, Cochrane Library, Web of Science, Cumulative Index to Nursing and Allied Health Literature, Med Ed Portal databases, and gray literature. All available prospective cohort studies, case reports, and narratives published up to July 2017 were eligible for review. Fourteen articles were identified and referenced palliative care education programs in Argentina, Uganda, Kenya, Australia, Germany, the USA, or multiple countries. The most common teaching strategy was lecture-based, followed by mentorship and experiential learning involving role play and simulation. Education topics included core principles of palliative care, pain and symptom management, and communication skills. Two programs included additional topics specific to the underserved or American Indian/Alaskan Native community. Only one program discussed supportive cancer care, and no program reported educational content on resource-stratified decision-making for palliative oncological treatment. Five programs reported positive participant satisfaction, and three programs described objective metrics of increased educational or research activity. There is scant literature on effective curricula for providers treating cancer patients in resource-limited settings. Emphasizing supportive cancer care and palliative oncologic treatments may help address gaps in education; increased outcome reporting may help define the impact of palliative care curriculum within resource-limited communities.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
5.
Zurück zum Zitat White MC, Espey DK, Swan J, Wiggins CL, Eheman C, Kaur JS (2014) Disparities in cancer mortality and incidence among American Indians and Alaska Natives in the United States. Am J Public Health 104(Suppl 3):377CrossRef White MC, Espey DK, Swan J, Wiggins CL, Eheman C, Kaur JS (2014) Disparities in cancer mortality and incidence among American Indians and Alaska Natives in the United States. Am J Public Health 104(Suppl 3):377CrossRef
10.
Zurück zum Zitat Bickel KE, McNiff K, Buss MK, Kamal A, Lupu D, Abernethy AP, Broder MS, Shapiro CL, Acheson AK, Malin J, Evans T, Krzyzanowska MK (2016) Defining high-quality palliative care in oncology practice: an American Society of Clinical Oncology/American Academy of Hospice and Palliative Medicine guidance statement. J Oncol Pract 12:828CrossRef Bickel KE, McNiff K, Buss MK, Kamal A, Lupu D, Abernethy AP, Broder MS, Shapiro CL, Acheson AK, Malin J, Evans T, Krzyzanowska MK (2016) Defining high-quality palliative care in oncology practice: an American Society of Clinical Oncology/American Academy of Hospice and Palliative Medicine guidance statement. J Oncol Pract 12:828CrossRef
13.
Zurück zum Zitat Riesel JN, Mandigo M, Gillies R, Damuse R, Farmer PE, Cusack JC, Krakauer EL, Shulman LN (2015) Surgical palliative care in resource-limited settings. Lancet (London, England) 386:5CrossRef Riesel JN, Mandigo M, Gillies R, Damuse R, Farmer PE, Cusack JC, Krakauer EL, Shulman LN (2015) Surgical palliative care in resource-limited settings. Lancet (London, England) 386:5CrossRef
15.
Zurück zum Zitat Ku G, Tan IB, Yau T, Boku N, Laohavinij S, Cheng AL, Kang YK, de Lima Lopes G (2012) Management of colon cancer: resource-stratified guidelines from the Asian Oncology Summit 2012. Lancet Oncol 13:470CrossRef Ku G, Tan IB, Yau T, Boku N, Laohavinij S, Cheng AL, Kang YK, de Lima Lopes G (2012) Management of colon cancer: resource-stratified guidelines from the Asian Oncology Summit 2012. Lancet Oncol 13:470CrossRef
16.
Zurück zum Zitat Shen L, Shan YS, Hu HM, Price TJ, Sirohi B, Yeh KH, Yang YH, Sano T, Yang HK, Zhang X, Park SR, Fujii M, Kang YK, Chen LT (2013) Management of gastric cancer in Asia: resource-stratified guidelines. Lancet Oncol 14:535CrossRef Shen L, Shan YS, Hu HM, Price TJ, Sirohi B, Yeh KH, Yang YH, Sano T, Yang HK, Zhang X, Park SR, Fujii M, Kang YK, Chen LT (2013) Management of gastric cancer in Asia: resource-stratified guidelines. Lancet Oncol 14:535CrossRef
18.
Zurück zum Zitat Payne S, Chan N, Davies A, Poon E, Connor S, Goh C (2012) Supportive, palliative, and end-of-life care for patients with cancer in Asia: resource-stratified guidelines from the Asian Oncology Summit 2012. Lancet Oncol 13:492CrossRef Payne S, Chan N, Davies A, Poon E, Connor S, Goh C (2012) Supportive, palliative, and end-of-life care for patients with cancer in Asia: resource-stratified guidelines from the Asian Oncology Summit 2012. Lancet Oncol 13:492CrossRef
19.
Zurück zum Zitat Hui D, Bruera E (2016) Integrating palliative care into the trajectory of cancer care. Nat Rev Clin Oncol 13:159–171CrossRefPubMed Hui D, Bruera E (2016) Integrating palliative care into the trajectory of cancer care. Nat Rev Clin Oncol 13:159–171CrossRefPubMed
20.
Zurück zum Zitat Vindrola-Padros C, Mertnoff R, Lasmarias C, Gomez-Batiste X (2017) Palliative care education in Latin America: a systematic review of training programs for healthcare professionals. Palliat Support Care 11:1–11 Vindrola-Padros C, Mertnoff R, Lasmarias C, Gomez-Batiste X (2017) Palliative care education in Latin America: a systematic review of training programs for healthcare professionals. Palliat Support Care 11:1–11
22.
Zurück zum Zitat Taroco AL Jr, Valente TC, Carbogim CS (2017) Distance learning for updating health professionals in palliative care: a systematic review. BMJ Support Palliat Care 7(2):205–211 Taroco AL Jr, Valente TC, Carbogim CS (2017) Distance learning for updating health professionals in palliative care: a systematic review. BMJ Support Palliat Care 7(2):205–211
26.
27.
Zurück zum Zitat Arenella C, Finke B, Domer T, Kaur JS, Merriman MP, Ousley A (2010) Adaptation, dissemination, and evaluation of a cancer palliative care curriculum for the Indian health system. J Palliat Care 26(1):15–21CrossRefPubMed Arenella C, Finke B, Domer T, Kaur JS, Merriman MP, Ousley A (2010) Adaptation, dissemination, and evaluation of a cancer palliative care curriculum for the Indian health system. J Palliat Care 26(1):15–21CrossRefPubMed
28.
Zurück zum Zitat De Simone GG (2003) Palliative care in Argentina: perspectives from a country in crisis. J Pain Palliat Care Pharmacother 17(3-4):23–43CrossRefPubMed De Simone GG (2003) Palliative care in Argentina: perspectives from a country in crisis. J Pain Palliat Care Pharmacother 17(3-4):23–43CrossRefPubMed
29.
Zurück zum Zitat Distelhorst SR, Cleary JF, Ganz PA, Bese N, Camacho-Rodriguez R, Cardoso F, Ddungu H, Gralow JR, Yip CH, Anderson BO, Breast Health Global Initiative Global Summit on Supportive Care and Quality of Life Consensus Panel Members. 2015 (2014) Optimisation of the continuum of supportive and palliative care for patients with breast cancer in low-income and middle-income countries: executive summary of the Breast Health Global Initiative. Lancet Oncol 16:137CrossRef Distelhorst SR, Cleary JF, Ganz PA, Bese N, Camacho-Rodriguez R, Cardoso F, Ddungu H, Gralow JR, Yip CH, Anderson BO, Breast Health Global Initiative Global Summit on Supportive Care and Quality of Life Consensus Panel Members. 2015 (2014) Optimisation of the continuum of supportive and palliative care for patients with breast cancer in low-income and middle-income countries: executive summary of the Breast Health Global Initiative. Lancet Oncol 16:137CrossRef
34.
Zurück zum Zitat Micheli A, Sanz N, Mwangi-Powell F, Coleman MP, Neal C, Ullrich A, Travado L, Santini LA, Grassi L, De Lorenzo F, Costa A, Dangou J-M, Bisanti L, Costantini AS, Abu-Rmeileh N, Kamal M, Federico M, Saracci R, Rennert G, Stefanini A, Cavalli F, Cazap E, Redmond K, O'Reilly S, Muti P, Casali P, Gatta G, Ferrari A, Koifman S, Bah E, Pastore G, Barr R, Lombardo C, Frazzingaro C, Ciampichini R, Baili P, Tumino R, Stracca Pansa V, Faravelli A, Giovenali P, Viberti L, Zanino T, Marelli P, Gil F, Greeff LE, Eldre S, El Mistiri M, El Sahli N, El Mangush M, Attia A, Shembesh R, El Arafi H, El Faidi A, Vilanova Marques CA, Rivero De Gutierrez MG, Niglio De Figueiredo E, Piccinini Feitosa TM, Braun R, Tomasini I, Khader J, Fobair PA, Soygur H, Akbiyik D, Otter R, Dore JF, Borras JM, Hernandez JE, Fitzpatrick J, Guillemette B, Hermann N, Holohan T, Lovely J, Moss T, Obrist R, Salmon Kaur J, DeCourtney C, Merriman M, Mangone L, Vicentini M, Pellegri C, Cilia S, Ma O, Crosignani P, Budroni M, Aurora F, Fattore G, Sant M, Di Salvo F, Zigon G, Trama A, Franklin Vasquez R, Bonilla ME, Favini F, Antillon-Klussman FG, Castellanos M, Valverde P, Garrido C, Favini F, Loh S-Y, Yip CH, Passmore A, Manicom C, Sutcliffe SB, Sarwal K, Torrance H, Sutcliffe CG, Amati C, Casella I (2009) International collaborations in cancer control and the Third International Cancer Control Congress. Tumori 95(5):579–596CrossRefPubMed Micheli A, Sanz N, Mwangi-Powell F, Coleman MP, Neal C, Ullrich A, Travado L, Santini LA, Grassi L, De Lorenzo F, Costa A, Dangou J-M, Bisanti L, Costantini AS, Abu-Rmeileh N, Kamal M, Federico M, Saracci R, Rennert G, Stefanini A, Cavalli F, Cazap E, Redmond K, O'Reilly S, Muti P, Casali P, Gatta G, Ferrari A, Koifman S, Bah E, Pastore G, Barr R, Lombardo C, Frazzingaro C, Ciampichini R, Baili P, Tumino R, Stracca Pansa V, Faravelli A, Giovenali P, Viberti L, Zanino T, Marelli P, Gil F, Greeff LE, Eldre S, El Mistiri M, El Sahli N, El Mangush M, Attia A, Shembesh R, El Arafi H, El Faidi A, Vilanova Marques CA, Rivero De Gutierrez MG, Niglio De Figueiredo E, Piccinini Feitosa TM, Braun R, Tomasini I, Khader J, Fobair PA, Soygur H, Akbiyik D, Otter R, Dore JF, Borras JM, Hernandez JE, Fitzpatrick J, Guillemette B, Hermann N, Holohan T, Lovely J, Moss T, Obrist R, Salmon Kaur J, DeCourtney C, Merriman M, Mangone L, Vicentini M, Pellegri C, Cilia S, Ma O, Crosignani P, Budroni M, Aurora F, Fattore G, Sant M, Di Salvo F, Zigon G, Trama A, Franklin Vasquez R, Bonilla ME, Favini F, Antillon-Klussman FG, Castellanos M, Valverde P, Garrido C, Favini F, Loh S-Y, Yip CH, Passmore A, Manicom C, Sutcliffe SB, Sarwal K, Torrance H, Sutcliffe CG, Amati C, Casella I (2009) International collaborations in cancer control and the Third International Cancer Control Congress. Tumori 95(5):579–596CrossRefPubMed
Metadaten
Titel
Palliative Oncologic Care Curricula for Providers in Resource-Limited and Underserved Communities: a Systematic Review
verfasst von
Melody J. Xu
David Su
Rebecca Deboer
Michael Garcia
Peggy Tahir
Wendy Anderson
Anne Kinderman
Steve Braunstein
Tracy Sherertz
Publikationsdatum
20.12.2017
Verlag
Springer US
Erschienen in
Journal of Cancer Education / Ausgabe 2/2019
Print ISSN: 0885-8195
Elektronische ISSN: 1543-0154
DOI
https://doi.org/10.1007/s13187-017-1310-8

Weitere Artikel der Ausgabe 2/2019

Journal of Cancer Education 2/2019 Zur Ausgabe

Neu im Fachgebiet Onkologie

Tisotumab-Vedotin verlängert Überleben nach Zervixkarzinom-Rezidiv

13.07.2024 Zervixkarzinom Nachrichten

Für Frauen mit rezidiviertem oder metastasiertem Zervixkarzinom und Versagen der Erstlinientherapie zeichnet sich eine Verbesserung der Behandlungsoptionen ab: Mit dem Antikörper-Wirkstoff-Konjugat Tisotumab-Vedotin überleben sie zwei Monate länger als mit einer Chemotherapie.

Was das Überwachen von Risikopersonen für Pankreaskrebs bringt

12.07.2024 Pankreaskarzinom Nachrichten

Programme zur Überwachung von Hochrisikokandidaten für duktales Adenokarzinom des Pankreas führen womöglich zu früherer Diagnose. Ob sich das auch in einem Überlebensvorteil niederschlägt, hat eine Studie getestet.

Prostatakarzinome der ISUP-Gruppe 1 nicht immer harmlos

11.07.2024 Prostatakarzinom Nachrichten

Nicht bei allen Prostatakarzinomen der Gleason-Graduierungsgruppe 1 kann man davon ausgehen, dass sie benigne sind. In einer Studie aus dem UKE Hamburg hatten auch in dieser Gruppe bestimmte Patienten ein deutlich erhöhtes Risiko für einen ungünstigen Verlauf.

Taugen Risikoscores für Schlaganfall und Blutungen auch bei Krebskranken?

Britische Registerdaten sprechen dafür, dass sich die Blutungsrisikoprädiktion bei Personen mit Vorhofflimmern, die zugleich an Krebs leiden, nicht einfach aus Kohorten ohne Krebs übertragen lässt.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.